Alveolar hemorrhage associated with tirofiban

Hemorragia alveolar asociada con tirofiban

Main Article Content

Abstract

We present the case of a patient with alveolar hemorrhage associated with tirofiban whose diagnosis was delayed because the initial signs went unnoticed, initially interpreting the condition as pneumonia. Early and accurate diagnosis is essential to guide the management of any type of bleeding complication in a patient with acute coronary syndrome (ACS), especially in the case of alveolar hemorrhage (AH).

Downloads

Download data is not yet available.

Article Details

Author Biographies

Alexander Aguilar Arias, UPB-CEDIMED

Residente de Radiología e Imágenes Diagnósticas UPB-CEDIMED, Medellín, Colombia. 

Catalina Aguilar Arias, UPB-CEDIMED

Estudiante de Medicina. Universidad Pontificia Bolivariana. Medellín, Colombia.

References

Neumann FJ, Sousa-Uva M, Ahlsson A, Alfonso F, Banning AP, et al. 2018 ESC/EACTS Guidelines on myocardial revascularization. Eur Heart J. 2019;40(2):87-165. https://doi.org/10.1093/eurheartj/ehy394.

Collet JP, Thiele H, Barbato E, Barthélémy O, Bauersachs J, et al. 2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. Eur Heart J. 2021;42(14):1289-1367. https://doi.org/10.1093/eurheartj/ehaa575.

Hu X, Wang W, Ye J, Lin Y, Yu B, Zhou L, Zhou Y, Dong H. Effect of GP IIb/IIIa inhibitor duration on the clinical prognosis of primary percutaneous coronary intervention in ST-segment elevation myocardial infarction with no-/slow-reflow phenomenon. Biomed Pharmacother. 2021;143:112196. https://doi.org/10.1016/j.biopha.2021.112196.

Bor WL, Zheng KL, Tavenier AH, Gibson CM, Granger CB, et al. Pharmacokinetics, pharmacodynamics, and tolerability of subcutaneous administration of a novel glycoprotein IIb/IIIa inhibitor, RUC-4, in patients with ST-segment elevation myocardial infarction. EuroIntervention. 2021;17(5):e401-e410. https://doi.org/10.4244/EIJ-D-21-00287.

Karathanos A, Lin Y, Dannenberg L, et al. Routine Glycoprotein IIb/IIIa Inhibitor Therapy in ST-Segment Elevation Myocardial Infarction: A Meta-analysis. Can J Cardiol. 2019;35(11):1576-1588. https://doi.org/10.1016/j.cjca.2019.05.003.

Zhou X, Peng H, Yin Y, Huang H, Zeng J, Ouyang F. Diffused alveolar hemorrhage: A rare and severe complication of tirofiban-induced thrombocytopenia. International Journal of Cardiology. 2016;206:93-94. https://doi.org/10.1016/j.ijcard.2016.01.020.

Citado por